Conduent (CNDT) Stock Forecast, Price & News

0 brokers have issued 1 year price targets for Conduent's stock. Their CNDT share price forecasts range from $4.50 to $4.50. On average, they expect the company's stock price to reach $4.50 in the next year. This suggests a possible upside of 38.5% from the stock's current price.
View analysts price targets for CNDT or view top-rated stocks among Wall Street analysts.

Conduent's stock was trading at $4.05 on January 1st, 2023. Since then, CNDT shares have decreased by 19.8% and is now trading at $3.25.
View the best growth stocks for 2023 here.

Conduent saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 3,340,000 shares, an increase of 35.8% from the April 30th total of 2,460,000 shares. Based on an average trading volume of 1,080,000 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.7% of the shares of the company are sold short.
View Conduent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our CNDT earnings forecast.

Conduent Incorporated (NASDAQ:CNDT) issued its quarterly earnings results on Tuesday, February, 14th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.05. The company earned $986 million during the quarter, compared to the consensus estimate of $994 million. Conduent had a negative net margin of 8.50% and a positive trailing twelve-month return on equity of 3.55%. Conduent's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.13 earnings per share.

ETFs with the largest weight of Conduent (NASDAQ:CNDT) stock in their portfolio include LeaderShares Activist Leaders ETF (ACTV).WisdomTree U.S. SmallCap Fund (EES).

Conduent issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.70 billion-$3.80 billion, compared to the consensus revenue estimate of $3.75 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other Conduent investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and

Conduent trades on the NASDAQ under the ticker symbol "CNDT."

Conduent's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.52%), Dimensional Fund Advisors LP (4.19%), William Blair Investment Management LLC (3.16%), State Street Corp (1.87%), Segall Bryant & Hamill LLC (1.76%) and Charles Schwab Investment Management Inc. (1.52%). Insiders that own company stock include A Scott Letier, Clifford Skelton, Louis Edward Keyes, Mark Simon Brewer, Michael E Krawitz and Stephen Henry Wood.
View institutional ownership trends.

Shares of CNDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNDT stock can currently be purchased for approximately $3.25.

Conduent (NASDAQ:CNDT) has a market capitalization of $709.94 million and generates $3.81 billion in revenue each year. The company earns $-182,000,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis.

The company employs 62,000 workers across the globe.

Conduent's mailing address is 100 CAMPUS DRIVE, FLORHAM PARK NJ, 07932. The official website for the company is www.conduent.com. The company can be reached via phone at (844) 663-2638 or via email at ir@conduent.com.